Hydroxychloroquine, Azithromycin in the Treatment of Covid-19
Status:
Not yet recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This study investigates the efficay and tolerance of 5-days course of hydroxychloroquine or
hydroxychloroquine and azithromycin of patients with COVID-19 infection. The investigators
will undertake a randomized, double-blind, controlled Trial in the region of Sousse Tunisia